Sales of domestic pharmaceutical firms up 20% in October

Published: 2009-11-20 06:59:00

Updated: 2009-11-20 06:59:00

The combined sales of the nine major domestic pharmaceutical manufacturing firms in October marked a growth rat of more than 20 percent from the same month of last year, according to market analysts.

Boosted by robust sales of flagship generic products, Chong Kung Dang Pharmaceutical and Dong-...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK